The atpF subunit is integral to the F₀ sector of the ATP synthase, which facilitates proton translocation across the bacterial membrane. Research highlights its interaction with virulence factors:
MgtC-Mediated Inhibition: MgtC, a Salmonella virulence protein, inhibits the F₁F₀ ATP synthase by binding to the a subunit (F₀ sector), disrupting proton translocation and ATP synthesis. This interaction maintains physiological ATP levels and cytoplasmic pH, enhancing bacterial survival within host macrophages .
Pathogenicity Link: Mutations in MgtC that impair ATP synthase inhibition reduce Salmonella virulence, underscoring atpF’s indirect role in pathogenicity .
Recombinant atpF is primarily used in:
SDS-PAGE: To confirm protein purity and structural integrity .
Enzymatic Studies: Investigating ATP synthase activity and its regulation by proteins like MgtC .
The protein serves as a tool to study Salmonella’s strategies to counteract host defenses, particularly in understanding how ATP synthase modulation contributes to intracellular survival .
While recombinant atpF has clarified its role in ATP synthase function, further studies are needed to:
Elucidate Subunit Interactions: Determine if atpF directly interacts with MgtC or other virulence factors.
Explore Host-Pathogen Dynamics: Investigate how ATP synthase modulation impacts Salmonella’s ability to evade host immune responses.
KEGG: sew:SeSA_A4079
The atpF gene encodes the b subunit of ATP synthase, a critical component of the F₀ sector in this molecular machine. ATP synthase uses a unique rotational mechanism to convert chemical energy into mechanical energy and vice versa. The b subunit serves as part of the peripheral stalk (stator) in ATP synthase, which prevents rotation of the F₁ domain during catalysis . In bacterial ATP synthases like that of Salmonella, subunit b exists as a dimer, with residues 62-122 particularly important for mediating this dimerization . The peripheral stalk formed partly by subunit b is crucial for stabilizing the c-ring/F₁ complex and maintaining the structural integrity needed for ATP synthesis to occur .
The b subunit of Salmonella ATP synthase forms an extremely elongated structure consisting primarily of α-helical elements. Analytical ultracentrifugation and solution small-angle X-ray scattering (SAXS) studies indicate that the b(62-122) dimer has a frictional ratio of 1.60, a maximal dimension of 95 Å, and a radius of gyration of 27 Å, consistent with an alpha-helical coiled-coil structure . Crystal structure analysis at 1.55 Å resolution has shown that the protein can crystallize as an isolated, monomeric alpha helix with a length of approximately 90 Å .
In bacterial ATP synthases, the N-terminal region of subunit b contains a single membrane-embedded α-helix that forms important interactions with subunit a. Notably, in the assembled complex, the two copies of subunit b make different interactions with subunit a - one interacts with transmembrane α-helices 1, 2, 3, and 4, while the other interacts with α-helices 5 and 6 and the loop between α-helices 3 and 4 .
The b subunit plays several critical roles in ATP synthase function:
As part of the peripheral stalk (b₂δ), it prevents rotation of the α₃β₃ hexamer during catalysis while allowing the γ subunit to rotate within it .
The C-terminal water-soluble part of subunit b displays significant conformational variability between rotational states, suggesting it contributes to the transient storage of torsional energy during rotation .
The b subunit's elongated structure allows it to span from the membrane to the top of the F₁ sector, accommodating the substantial distance while remaining flexible enough to adapt to different rotational states .
Cryo-EM studies have revealed that the peripheral stalk in bacteria is structurally simpler and more flexible than in yeast mitochondria, suggesting that bacterial subunits a and the c-ring are mainly held together by hydrophobic interactions rather than by the peripheral stalk .
Several expression systems can be used for recombinant Salmonella atpF production, each with specific advantages:
| Expression System | Advantages | Disadvantages | Best Applications |
|---|---|---|---|
| E. coli BL21(DE3) | High yield, simple culture conditions | Potential inclusion body formation | Basic structural studies |
| E. coli DK8 strain | Lacks endogenous ATP synthase | More specialized strain | Functional studies |
| Yeast systems | Better protein folding | Lower yield | Studies requiring eukaryotic-like modifications |
| Baculovirus/insect cells | Excellent for complex proteins | Expensive, technically demanding | Detailed structural studies |
For most applications, E. coli remains the system of choice due to its simplicity and cost-effectiveness . Specifically, the DK8 strain (which lacks endogenous ATP synthase) has been successfully used for expressing ATP synthase components from various bacteria .
A comprehensive purification protocol for high-purity recombinant atpF would include:
Cell lysis: Using French Press in buffer containing protease inhibitors .
Membrane preparation: Differential centrifugation at 35,000 rpm for 30 minutes to remove cell debris .
Affinity chromatography: Application to Ni²⁺-NTA column equilibrated with 20 mM imidazole and 100 mM NaCl (pH 7.0), washing with 50 mM imidazole, and elution with 500 mM imidazole .
Size exclusion chromatography: Further purification using Superdex 200 column to separate monomeric, dimeric, and aggregated forms.
Storage: Either as precipitate in 70% saturated ammonium sulfate at 4°C or in buffer containing glycerol at -80°C .
This protocol typically yields protein of >95% purity suitable for crystallography, cryo-EM, or other high-resolution structural techniques.
Researchers commonly encounter several challenges when working with atpF:
| Challenge | Possible Causes | Solutions |
|---|---|---|
| Poor expression | Toxicity, codon bias | Use tightly regulated expression systems, optimize codons |
| Inclusion body formation | Rapid expression, improper folding | Lower induction temperature (16-20°C), reduce inducer concentration |
| Membrane integration issues | Overloading membrane machinery | Use specialized strains (C41/C43), include proper signal sequences |
| Aggregation during purification | Hydrophobic interactions | Screen detergents (DDM, digitonin), include glycerol |
| Low yield of dimeric form | Disruption of dimer interface | Avoid harsh purification conditions, use chemical cross-linking |
A systematic troubleshooting approach involves sequential optimization of expression temperature, induction conditions, lysis methods, and purification buffers . When working with the transmembrane domain, screening different detergents is critical.
Mutations in atpF have provided valuable insights into structure-function relationships in ATP synthase:
Particularly informative mutations include those in the N-terminal transmembrane helix that disrupt interactions with subunit a, preventing proper assembly of the F₀ sector. This region is critical as the two copies of subunit b make different interactions with subunit a in the assembled complex .
Verification of recombinant atpF should include both structural and functional assessments:
Structural integrity validation:
Circular dichroism (CD) spectroscopy to confirm α-helical content
Size exclusion chromatography to determine oligomeric state
Thermal shift assays to assess protein stability
Limited proteolysis to evaluate domain structure
Functional validation:
Complementation assays in atpF-deficient bacterial strains
Reconstitution studies with other ATP synthase components
ATP synthesis/hydrolysis assays when incorporated into ATP synthase complex
Proton-pumping assays using pH-sensitive fluorescent dyes
Binding assays with known partner subunits (e.g., subunit a, δ)
The combination of these approaches provides comprehensive validation of recombinant atpF and ensures that any subsequent experimental findings are based on properly folded and functional protein.
Several advanced biophysical techniques can provide insights into atpF dynamics:
Single-molecule FRET: By labeling specific residues in atpF and interacting subunits with donor-acceptor fluorophore pairs, conformational changes during rotation can be monitored in real-time with nanometer precision .
High-speed atomic force microscopy (HS-AFM): This allows visualization of structural changes in the peripheral stalk during ATP hydrolysis or synthesis.
Time-resolved cryo-EM: By rapidly freezing samples at different stages of the catalytic cycle, structural intermediates can be captured and reconstructed .
Hydrogen-deuterium exchange mass spectrometry (HDX-MS): This technique can identify regions of atpF that undergo conformational changes or exhibit different solvent accessibility during the catalytic cycle.
Site-directed spin labeling with electron paramagnetic resonance (EPR): This approach can measure distances between specific sites and detect conformational changes with high precision.
When designing expression vectors for atpF, researchers should consider:
Promoter selection:
Tag placement:
Truncation strategy:
Multisubunit expression:
Example vector designs that have proven successful include pET-based vectors with N-terminal His₁₀ tags for high-yield purification .
Protein engineering approaches can provide valuable insights into atpF function:
Deletion analysis:
Site-directed mutagenesis:
Alanine scanning of interface residues to identify key interaction points
Introduction of cysteine pairs for disulfide cross-linking to stabilize specific conformations
Charge reversal mutations to disrupt electrostatic interactions
Domain swapping:
Replacing segments of atpF with corresponding regions from other species can identify species-specific functional elements
Chimeric constructs between related ATP synthase b subunits can map functional domains
Fusion protein approaches:
Reporter protein fusions can track localization and assembly
Split-protein complementation assays can monitor protein-protein interactions in vivo
FRET pair insertions at specific sites can report on conformational changes
These approaches have been successfully applied to other ATP synthase subunits and could be adapted for atpF studies .
AtpF can serve as a valuable tool for investigating antimicrobial resistance:
Energy metabolism connections:
ATP synthase provides energy for efflux pumps and other resistance mechanisms
Mutations affecting energy production can impact susceptibility to antimicrobials
Modified energy metabolism is a known adaptation in resistant strains
Experimental approaches:
Conditional expression systems can help identify energy requirements for resistance mechanism function
Metabolic flux analysis using atpF mutants can reveal adaptations in resistant strains
Comparative studies between susceptible and resistant isolates may reveal differences in ATP synthase function
Recent studies have shown that antimicrobial resistance genes are common among Salmonella Schwarzengrund isolates, with 61.7% carrying at least one AMR gene . The most commonly observed resistance genes include aph(3'')-Ib (aminoglycoside; 47.1%), tet(A) (tetracycline; 9.2%) and sul2 (sulfonamide; 7.3%) . The energy demands of expressing these resistance mechanisms may create selective pressure for adaptations in ATP synthase function.
AtpF contributes to Salmonella pathogenesis through several mechanisms:
Energy provision for virulence factor expression:
Adaptation to host environments:
Intracellular Salmonella must adjust energy metabolism to nutrient-limited conditions
ATP synthase activity may be regulated differently in host cells
Proton gradient maintenance is essential for survival in acidic phagosomes
Therapeutic implications:
Understanding the regulation of atpF expression during infection is particularly relevant for developing interventions. Secretion systems essential for Salmonella virulence depend on the energy provided by ATP synthase, suggesting that atpF indirectly contributes to pathogenesis .
Recombinant Salmonella atpF has several potential applications in vaccine research:
Component of subunit vaccines:
Design of attenuated live vaccines:
Diagnostic applications:
Antibodies against atpF can serve as markers of Salmonella infection
Strain-specific variations in atpF can be exploited for serotyping
Research in recombinant attenuated Salmonella vaccines has demonstrated that regulating key genes involved in metabolism can create vaccines that efficiently colonize lymphoid tissues without causing disease symptoms, resulting in long-lasting protective immune responses .
Comparative analysis of atpF across Salmonella serovars may reveal important structural adaptations related to host range and virulence. While the core function of ATP synthase is conserved, subtle variations in the sequence and structure of atpF could affect:
Protein-protein interactions within the ATP synthase complex
Energy production efficiency under different environmental conditions
Stability of the complex in various host-associated environments
Immunogenicity and recognition by host immune systems
Systematic comparison of atpF sequences from host-restricted serovars (like S. Typhi) versus broad-host-range serovars (like S. Typhimurium) could identify key residues associated with host adaptation . Such studies would benefit from combining structural biology approaches with functional assays and in vivo infection models.
For particularly challenging atpF constructs, several innovative approaches could be explored:
Cell-free protein synthesis systems:
Avoid toxicity issues associated with overexpression
Allow direct incorporation of non-canonical amino acids for biophysical studies
Enable rapid screening of different detergents and buffer conditions
Novel fusion partners:
Engineered highly soluble proteins as N-terminal fusion partners
Nanobodies or designed ankyrin repeat proteins (DARPins) that bind specific conformations
Split-inteins for purification of otherwise insoluble constructs
Directed evolution strategies:
Alternative host systems:
Extremophiles for expression of thermostable variants
Cell lines derived from natural Salmonella hosts
Synthetic minimal cells with customized expression machinery
These approaches could help overcome the economic, efficiency, and environmental challenges that currently limit the industrial-scale production of recombinant proteins for research and therapeutic applications .